CytoDyn Inc. Files 10-Q for Period Ending Feb 28, 2025

Ticker: CYDY · Form: 10-Q · Filed: Apr 14, 2025 · CIK: 1175680

Cytodyn Inc. 10-Q Filing Summary
FieldDetail
CompanyCytodyn Inc. (CYDY)
Form Type10-Q
Filed DateApr 14, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, financials, pharmaceuticals

TL;DR

CYDY 10-Q filed for Feb 28, 2025. Financials updated.

AI Summary

CytoDyn Inc. filed its 10-Q for the period ending February 28, 2025. The company's fiscal year ends on May 31st. Key financial data points and disclosures related to its common stock and treasury stock are included in this filing.

Why It Matters

This filing provides investors with an update on CytoDyn Inc.'s financial position and operational status for the specified period, crucial for understanding the company's performance.

Risk Assessment

Risk Level: medium — As a pharmaceutical company, CytoDyn Inc. faces inherent risks related to drug development, regulatory approvals, and market competition, which are typical for the industry.

Key Numbers

  • 0531 — Fiscal Year End (Indicates the end of the company's annual financial reporting cycle.)
  • 20250228 — Reporting Period End Date (The date up to which the financial information in the 10-Q is reported.)

Key Players & Entities

  • CytoDyn Inc. (company) — Filer of the 10-Q
  • February 28, 2025 (date) — End of the reporting period
  • May 31 (date) — Fiscal year end
  • 1111 MAIN STREET, SUITE 660 (address) — Company's business and mail address
  • VANCOUVER, WA 98660 (address) — Company's business and mail city, state, and zip

FAQ

What is the primary business of CytoDyn Inc.?

CytoDyn Inc. is primarily involved in the Pharmaceutical Preparations industry, as indicated by its Standard Industrial Classification code [2834].

When is CytoDyn Inc.'s fiscal year end?

CytoDyn Inc.'s fiscal year ends on May 31st (0531).

What is the filing date of this 10-Q report?

This 10-Q report was filed on April 14, 2025.

What is the SEC file number for CytoDyn Inc.?

The SEC file number for CytoDyn Inc. is 000-49908.

Where is CytoDyn Inc. located?

CytoDyn Inc.'s business and mail address is 1111 MAIN STREET, SUITE 660, VANCOUVER, WA 98660.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on April 14, 2025 regarding CytoDyn Inc. (CYDY).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.